✦ LIBER ✦

Prevalence of HIV-1 drug resistance mutations among Spanish prison inmates

✍ Scribed by J. García-Guerrero; P. Sáiz de la Hoya; J. Portilla; A. Marco; J. Sánchez-Payá; S. Moreno; Estudio de Resistencias en Prisiones Group

Publisher: Springer
Year: 2006
Tongue: English
Weight: 127 KB
Volume: 25
Category: Article
ISSN: 0934-9723
DOI: 10.1007/s10096-006-0206-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

HIV-1 diversity among inmates of Italian

HIV-1 diversity among inmates of Italian prisons

✍ Benedetta Longo; Stefano Novati; Stefania Montieri; Emanuele Pontali; Fabiana Ta 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

## Abstract In Italy, the prevalence of non‐B HIV‐1 subtypes ranges reportedly from 5.4% to 12.6%, yet there are no data on their circulation in prisons, where the prevalence of HIV infection is high. A retrospective study was conducted to evaluate the circulation of non‐B subtypes and to character

Prevalence and pattern of drug resistanc

Prevalence and pattern of drug resistance mutations among antiretroviral-treated HIV-1 patients with suboptimal virological response in Malaysia

✍ Kok Keng Tee; Adeeba Kamarulzaman; Kee Peng Ng 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 235 KB

Low prevalence of transmitted drug resis

Low prevalence of transmitted drug resistance among newly diagnosed HIV-1 patients in Latvia

✍ Dace Balode; Maj Westman; Tatjana Kolupajeva; Baiba Rozentale; Jan Albert 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

## Abstract Transmitted drug resistance (TDR) is a concern because it may reduce the efficacy of antiretroviral treatment. Plasma samples of 119 HIV‐1‐infected patients who were newly diagnosed at the Infectology Center of Latvia in 2005 and 2006 were analyzed by an in‐house genotypic resistance as

Profile of drug resistance mutations amo

Profile of drug resistance mutations among HIV-1-infected Tunisian subjects failing antiretroviral therapy

✍ A. Jlizi; A. Ben Ammar El Gaaied; A. Slim; F. Tebourski; M. Ben Mamou; T. Ben Ch 📂 Article 📅 2008 🏛 Springer Vienna 🌐 English ⚖ 239 KB

Molecular epidemiology and prevalence of

Molecular epidemiology and prevalence of drug resistance-associated mutations in newly diagnosed HIV-1 patients in Portugal

✍ A.C. Palma; F. Araújo; V. Duque; F. Borges; M.T. Paixão; R. Camacho 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 253 KB

Persistence of earlier HIV-1 drug resist

Persistence of earlier HIV-1 drug resistance mutations at new treatment failure

✍ Veronica Svedhem; Annica Lindkvist; Knut Lidman; Anders Sönnerborg 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

## Abstract The objective was to study the persistence of drug resistance mutations detected earlier at virological failure during second or third line antiretroviral therapy. Therefore, in HIV‐1 infected patients, with a virological treatment failure, genotypic resistance testing was carried out b